Dr. Daniel Stephen Kasprick, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1455 S Lapeer Rd Ste 110, Lake Orion, MI 48360 Phone: 248-923-5345 |
Dr. Allan Richard Rinke Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1376 S Lapeer Rd Ste A, Lake Orion, MI 48360 Phone: 248-693-3380 Fax: 248-693-0910 |
News Archive
Ben-Gurion University of the Negev researchers have improved a standard bariatric surgery clinical scoring system (DiaRem) to extend the prediction time for diabetic remission following bariatric (weight-loss) surgery.
AHF's Magic Johnson ‘Testing America' Tour, a six-month, 48-state national cross-country HIV testing tour, will ride into Dallas/Ft. Worth, Texas, for four days of testing events. AIDS Healthcare Foundation (AHF) will join Commissioner Marti VanRavenswaay (Precinct 2) at a press conference Tuesday, February 2nd, at 2:00 p.m. at the Tarrant County Precinct 2 office - 700 E. Abrams St., Suite #304, Arlington, TX 76010-1239 to announce the arrival of the mobile unit and to promote testing in the days leading up to National Black HIV/AIDS Awareness Day (Sunday, February 7th).
All-Terrain Vehicles (ATVs) are associated with a significant and increasing number of hospitalizations for children in the U.S., according to a new report by the Center for Injury Research and Policy at the Johns Hopkins Bloomberg School of Public Health. Over a nine- year period (1997-2006) hospitalizations for ATV injuries increased 150 percent among youth younger than 18 years, with important demographic variations.
In a perspective article recently published in the journal Science, Hyeryun Choe and Michael Farzan from the Scripps Research Institute, USA, have described the early-stage evolution of SARS-CoV-2 in humans. They have provided a detailed overview of how early mutations in SARS-CoV-2 spike protein facilitate its adaptation in human systems.
Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced enrollment of the first patient in its pivotal Phase 2b study of OTO-104 for the reduction of vertigo in patients with unilateral Meniere's disease.
› Verified 7 days ago